Ultrathin Parylene C-based sensitivity-gain nanoplasmonic sensor integrated on VCSEL for Aβ42 detection

Biosens Bioelectron. 2024 Jun 15:254:116220. doi: 10.1016/j.bios.2024.116220. Epub 2024 Mar 16.

Abstract

As Alzheimer's disease prevalence continues to rise, there is an increasing demand for efficient on-chip biosensors capable of early biomarker detection. This study presents a novel biosensor chip leveraging vertical cavity surface emitting laser (VCSEL) technology, with Parylene C serving as the antibody coupling layer and utilizing a streamlined one-step antibody modification method. Integration of Parylene C enhances chip sensitivity from 34.28 μW/RIU to 40.32 μW/RIU. Moreover, post-testing removal of Parylene C enables chip reusability without significant alteration of results. The sensor demonstrates effective detection of Aβ42, an Alzheimer's biomarker, exhibiting a linear range of 1-200 ng/mL and a detection limit of 0.26 ng/mL. These findings underscore the reusability and reliability of the ultrathin Parylene C-based VCSEL biosensor chip, highlighting its potential for point-of-care Alzheimer's disease diagnosis.

Keywords: Biosensor; LSPR; Parylene C; Sensitivity gain; VCSEL.

MeSH terms

  • Alzheimer Disease* / diagnosis
  • Biomarkers
  • Biosensing Techniques* / methods
  • Humans
  • Lasers
  • Polymers*
  • Reproducibility of Results
  • Xylenes*

Substances

  • parylene
  • Biomarkers
  • Polymers
  • Xylenes